Home » Newsletters » BioWorld Science

BioWorld Science

May 5, 1998

View Archived Issues

Two-vaccine combination for HIV shows promise in clinical trial

Company Profile: Immusol

BRL-49653 may mediate insulin sensitivity by reducing FFA release from adipocytes

HMG-CoA reductase inhibition upregulates ecNOS expression in vitro

Zeneca seeks new labeling for breast cancer therapy

Extended-release formulation of carbamazepine launched in U.S.

Interneuron granted license to PACAP technology

Enzo Biochem receives SBIR grant to support development of AIDS drug

New AIDS immunotherapeutic in development by Australian company

Bindarit development redirected toward SLE indication

Takeda developing carbapenems for Gram-negative infections

Antitumor agents of microbial origin discovered by Nippon Kayaku

Taisho prepares new cytokine inhibitors for inflammatory, allergic and other disorders

Sumitomo claims beta-lactams active against resistant staphylococci

Dainippon discloses pyridines for CNS disorders

Natural antitumor substances with broad-spectrum activity isolated by Banyu scientists

Phase I trial results presented for the antifolate LY-231514

First market introduction for Alcon's newest ophthalmic drug

Genentech files for marketing approval of Herceptin

New antidiabetic agent in the pipeline at Sumitomi Metal

Harvard Scientific unveils new treatment for female sexual dysfunction

NitroMed completes mezzanine financing, reviews development plans

Surfaxin as ARDS treatment enters phase II/III

Novo Nordisk discovers potent sst4 receptor agonist

GenVec in-licenses rights to TNF-alpha for gene therapy applications

Generex completes proof-of-concept trials with oral insulin

Chiron, HMR establish vaccines joint venture in India

Elan to acquire Neurex

Development status of Japan Tobacco's PEP inhibitor

Solarase receives additional European approvals

Baxter completes acquisition of Somatogen

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...